Scotland · NHS Scotland MSAN
Pancreatic enzyme replacement therapy (PERT)
MSAN(2024)24 · Level 2 · issued 13 May 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Creon® 10,000 and 25,000 gastro-resistant capsules are in limited supply until 2026. | Limited supply | 2026 |
| 2. Nutrizym® 22 capsules are out of stock until mid-August 2024. | Out of stock | mid-August 2024 |
| 3. Pancrex V® capsules and powder remain available but are unable to support an increase in | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.